News

Emergent: FDA letting troubled COVID vaccine factory restart

today07/29/2021 23

Background
share close

The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine. The Baltimore factory was shut down by the FDA in mid-April due to contamination problems that forced the company to trash the equivalent of tens of millions of doses of vaccine it was making under contract for Johnson & Johnson. The bulk vaccine was contaminated with an ingredient for AstraZeneca’s COVID-19 vaccine, which was being made in the same factory. Emergent on Thursday did not say exactly when production will resume at the factory.

All contents © copyright 2021 Associated Press. All rights reserved

Written by: Editor

Rate it

Previous post

News

Lollapalooza to require vaccination card or negative test

The hordes of people expected to descend on Chicago’s Grant Park for the Lollapalooza music festival this week will be required to show proof that they’ve been vaccinated for COVID-19 or tested negative for the disease within the last three days. The four-day festival starts Thursday and is expected to be back at full capacity, with roughly 100,000 daily attendees. After missing last summer because of the coronavirus, it will […]

today07/29/2021 5

0%